Should Lilly Stock Before April 10 Be on Your Radar?
As April 10 approaches, investors debate whether Lilly stock is a buy. This guide breaks down catalysts, valuation, a...
Learn how to effectively engage in virtual networking for financial planners to expand your reach and connect with industry experts.
16,067 articlesAs April 10 approaches, investors debate whether Lilly stock is a buy. This guide breaks down catalysts, valuation, a...
Oil shocks are roiling tech-heavy markets, but the Dow Jones keeps a steady hand. This piece breaks down what the spl...
In 2026, institutional buyers are quietly signaling confidence in diversified energy stocks. A recent stake near $20 ...
Two popular healthcare ETFs sit at the crossroads of broad exposure and biotech precision. This guide helps you decid...
Bitcoin vaulted past $70,000 in minutes, sending a broad risk-on rally across assets. Analysts warn the move produced...
A big stake in Sotera Health has caught the market's eye as shares slide. This article breaks down what a $175 millio...
A seasoned fund boosted its stake in ZoomInfo, revealing a confident bet on GTM's growth story. This article explains...
Oil stays above $100 as Trump signals a potential exit from Iran policy, creating volatility and shaping the midterm ...
Tesla reports its first European sales uptick in over a year, a modest but meaningful turn that investors are watchin...
Missouri Sen. Josh Hawley has launched a formal inquiry into FICO’s pricing of mortgage credit scores, seeking FTC sc...
Delek Logistics Partners has logged 13 years of rising payouts, but 2025 cash flow barely covers distributions, promp...
An insurer’s blockbuster profit alongside an insider stock sale creates a compelling investing puzzle. This article b...